Overview
Chonluten is a short bioregulatory tripeptide (Glu-Asp-Gly) studied for supporting bronchopulmonary tissue function and modulating inflammatory pathways in cellular models.
What It Is
“Chonluten (Glu‑Asp‑Gly) is a short bioregulatory peptide studied within the Khavinson peptide bioregulator framework targeting bronchopulmonary tissues.” Research using monocyte/macrophage cell cultures suggests it may influence proliferative activity and inflammatory signaling at nanomolar concentrations.
Administration Route
Due to poor oral stability, subcutaneous injection is the indicated parenteral delivery method for short peptides in this class.
Reconstitution
– Volume: Add 3.0 mL bacteriostatic water to the 20mg vial
– Final Concentration: 6.67 mg/mL
– Measurement: 1 unit (U-100 insulin syringe) = approximately 66.67 mcg
Reconstitution Steps
1. Draw 3.0 mL sterile bacteriostatic water
2. Inject slowly along vial wall; avoid foaming
3. Gently swirl/roll until completely dissolved
4. Label and store at 2–8°C (35.6–46.4°F), protected from light
Dosing Protocol
Standard Gradual Titration (8–16 weeks)
| Week | Daily Dose | Units per Injection |
|---|---|---|
| 1–2 | 250 mcg | 3.75 units |
| 3–4 | 500 mcg | 7.5 units |
| 5–6 | 1,000 mcg | 15 units |
| 7–8 | 1,500 mcg | 22.5 units |
| 9–10 | 2,000 mcg | 30 units |
| 11–12 | 3,000 mcg | 45 units |
| 13–16 | 4,000 mcg | 60 units |
Frequency: Once daily via subcutaneous injection
Duration: 8–16 weeks with incremental increases every 1–2 weeks
Dosing Approach: Begin at 250 mcg; increase by 250–500 mcg weekly as tolerated, reaching maximum 4,000 mcg by week 13
Storage Instructions
Lyophilized (unopened):
– Short-term: 4°C (39.2°F) in dry, dark conditions
– Long-term: −20°C (−4°F) or colder
After Reconstitution:
– Store at 2–8°C (35.6–46.4°F)
– Use within days to weeks
– Avoid repeated freeze-thaw cycles
– Allow vials to reach room temperature before opening to minimize condensation
Injection Technique
– Clean vial stopper and injection site with alcohol; allow to dry
– Pinch skin; insert needle at 45° angle using 25–27 gauge, ⅝-inch needle
– Do not aspirate for subcutaneous injections
– Inject slowly and steadily
– Rotate sites systematically (abdomen, thighs, upper arms)
– Wait several seconds before withdrawing needle
Supplies Needed (Per Protocol Duration)
For 8 weeks: ~3 vials, 56 syringes, 1 bottle bacteriostatic water (10mL), 2 boxes alcohol swabs
For 12 weeks: ~6 vials, 84 syringes, 2 bottles bacteriostatic water, 2 boxes alcohol swabs
For 16 weeks: ~12 vials, 112 syringes, 4 bottles bacteriostatic water, 3 boxes alcohol swabs
Potential Benefits
Based on preclinical research, Chonluten may:
– Support bronchopulmonary tissue regulation
– Modulate inflammatory and proliferative pathways in immune cells
– Demonstrate favorable tolerability profiles in laboratory settings
Side Effects & Considerations
– Short peptides in this class generally show favorable tolerability
– Occasional mild injection-site reactions (redness, itching) may occur
– Use new sterile syringes; dispose in sharps container
– Document daily doses and site rotation for consistency
Lifestyle Factors
– Maintain antioxidant-rich diet for respiratory tissue health
– Engage in regular aerobic activity appropriate to fitness level
– Prioritize sleep and stress management
– Avoid smoking and respiratory irritants
Important Notes
– For initial low-volume doses (≤10 units during weeks 1–4), consider 30- or 50-unit insulin syringes for improved accuracy
– This protocol is for research/educational purposes only
– Not intended for human consumption
– Consult qualified healthcare professionals before use
– Third-party tested, high-purity products recommended